A novel deletion involving the first GNAS exon encoding Gsα causes PHP1A without methylation changes at exon A/B

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology

Background:

• Pseudohypoparathyroidism type 1A (PHP1A) is characterized by hormonal resistance and skeletal abnormalities.
• PHP1A arises from genetic variants in the GNAS gene, affecting the G protein alpha subunit (Gsα).
• Albright Hereditary Osteodystrophy (AHO) is a common clinical feature in PHP1A patients.

Observation:

• A de novo 1284-bp deletion in GNAS exon 1 was identified in a male PHP1A patient.
• This deletion overlaps with a previously reported deletion, extending from the exon 1 promoter into an intronic region.
• The patient's DNA showed no epigenetic GNAS defect, unlike typical pseudohypoparathyroidism type 1B (PHP1B) cases.

Findings:

• The identified deletion refines the understanding of the critical region for establishing maternal methylation imprints at the GNAS exon A/B differentially methylated region (DMR).
• Nucleotide deletions within a ~1300-bp region telomeric of exon A/B may cause PHP1B with altered methylation.
• MLPA (Multiplex Ligation-dependent Probe Amplification) is recommended for detecting structural GNAS abnormalities in PHP1A diagnostics.

Implications:

• This study helps delineate the genetic and epigenetic mechanisms underlying pseudohypoparathyroidism subtypes.
• Identifying structural GNAS variants is crucial for accurate PHP1A diagnosis.
• Further research into the regulatory elements within the identified GNAS region is warranted.